Clinical Trials
3 trialsNCT00634504 2022-06-06
LVPK
BTG International Inc.
Phase 1 Completed
NCT00219791 2014-09-11
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
BTG International Inc.
Phase 2 Completed
NCT00481559 2014-01-17
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
BTG International Inc.
Approved for marketing